Anti-diabetic market getting heated

Competition is about to heat up in the domestic anti-diabetic market, as more and more new medicines for diabetes are lining up side by side with dominant imported drugs, such as Januvia, Galvus, Trajenta and Onglyza.

Takeda Korea is also about to set foot in the market with its Nesina (alogliptin) for the treatment of type 2 diabetes in adults as adjuncts to diet and exercise, raising the p...